Arda Taşatargil

619 citations
39 papers · 506 indexed · h-index 14
Topics
PARP inhibition in cancer therapy (6 papers)Neuropeptides and Animal Physiology (5 papers)Folate and B Vitamins Research (5 papers)

In The Last Decade

Arda Taşatargil

39 papers receiving 497 citations

Peers

Arda Taşatargil
Comparison fields: 5 of 93
  • Molecular Biology 110
  • Physiology 79
  • Cardiology and Cardiovascular Medicine 65
  • Oncology 61
  • Rheumatology 52
Replace Ali Ayçiçek with:
Ali Ayçiçek Türkiye
Luping Ren China
Arleta Drozd Poland
Panagiotis Konstantopoulos Greece
Daniel Castellano‐Castillo Spain
Hakan Türkön Türkiye
Qi Zhao United States
Denise Frediani Barbeiro Brazil
Huaqi Zhang China
Arda Taşatargil relative to Ali Ayçiçek Türkiye Ali Ayçiçek's profile →
Citations per field
00.5×1.5×2.3×
Ali Ayçiçek · 1×
Citations per year

Countries citing papers authored by Arda Taşatargil

Since Specialization
Citations

This map shows the geographic impact of Arda Taşatargil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arda Taşatargil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arda Taşatargil more than expected).

Fields of papers citing papers by Arda Taşatargil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arda Taşatargil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arda Taşatargil. The network helps show where Arda Taşatargil may publish in the future.

Co-authorship network of co-authors of Arda Taşatargil

This figure shows the co-authorship network connecting the top 25 collaborators of Arda Taşatargil. A scholar is included among the top collaborators of Arda Taşatargil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arda Taşatargil. Arda Taşatargil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 10
3 10
4 4
5 28
6 11
7 50
8 29
9 17
10 17
11 8
12 4
13 5
14 12
15 22
16 12
17 4
18 19
19 13
20 5

About Arda Taşatargil

Arda Taşatargil is a scholar working on Cardiology and Cardiovascular Medicine, Reproductive Medicine and Rheumatology, having authored 39 papers that have together received 506 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Neuropeptides and Animal Physiology (5 papers) and Folate and B Vitamins Research (5 papers). The work is most often cited by research in Drug Discovery (1 citation), Geriatrics and Gerontology (19 citations) and Reproductive Medicine (38 citations). Arda Taşatargil has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Çiler Çelik-Özenci, Selvinaz Dalaklıoğlu, Sadi S. Özdem, Leyla Satı, Nazif Hikmet Aksoy, Ramazan Demir, Sebahat Özdem, Gamze Tanrιöver, Fedai Erler and Mustafa Faruk Usta. Their work appears in journals such as European Journal of Pharmacology, Anesthesia & Analgesia and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026